Early Infantile Epileptic Encephalopathy In Asparagine-Linked Glycosylation Thirteen (ALG13) Gene Defect And Dramatic...

Area of Science:

• Biochemistry
• Genetics
• Neurology

Background:

• Congenital disorders of glycosylation (CDGs) are a group of rare genetic diseases.
• Asparagine-linked glycosylation thirteen (ALG13) gene mutations lead to specific CDGs, presenting with severe neurological and developmental issues.
• Data on ALG13-CDG globally is limited.

Observation:

• A young girl with ALG13-CDG experienced severe early onset epileptic encephalopathy (EEO), developmental delays (DD), and intellectual disability (ID).
• Her clinical management included standard therapies, but seizures persisted.
• The ketogenic diet (KD) was introduced as an adjunctive therapy.

Findings:

• The addition of a ketogenic diet (KD) led to a remarkable reduction in seizure frequency and severity.
• This suggests a potential metabolic benefit of KD in managing ALG13-CDG related epilepsy.
• The patient also showed improvements in other associated symptoms.

Implications:

• This case highlights the potential efficacy of ketogenic diets (KD) in managing refractory epilepsy associated with ALG13-CDG.
• Further research and clinical trials are crucial to validate these findings and explore KD's role in ALG13-CDG management.
• Improved understanding and identification of ALG13-CDG can lead to better patient outcomes, especially in populations with high consanguinity rates.